Phase 3 randomized, open-label study to evaluate Eflornithine with Lomustine compared to Lomustine (STELLAR) alone in patients with Anaplastic Astrocytoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Orbus Therapeutics, Inc.
Start Date
October 1, 2016
End Date
July 15, 2022
Administered By
Duke Cancer Institute
Awarded By
Orbus Therapeutics, Inc.
Start Date
October 1, 2016
End Date
July 15, 2022